BDBM380319 N-[3-methyl-4-(4-oxo- 3,4-dihydrophthalazin- 1-yl)phenyl]-1-[(3- methyloxetan-3- yl)methyl]-1H-indazole- 3-carboxamide::US9926282, Example 314

SMILES Cc1cc(NC(=O)c2nn(CC3(C)COC3)c3ccccc23)ccc1-c1n[nH]c(=O)c2ccccc12

InChI Key InChIKey=AGYQKQZXKQRNAQ-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 380319   

TargetRho-associated protein kinase 2(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM380319(N-[3-methyl-4-(4-oxo- 3,4-dihydrophthalazin- 1-yl)...)
Affinity DataIC50: <100nMAssay Description:The effectiveness of compounds of the present invention as ROCK inhibitors can be determined in a 30 μL assay containing 20 mM HEPES, pH 7.5, 20...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetRho-associated protein kinase 1(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM380319(N-[3-methyl-4-(4-oxo- 3,4-dihydrophthalazin- 1-yl)...)
Affinity DataIC50: <100nMAssay Description:The effectiveness of compounds of the present invention as ROCK inhibitors can be determined in a 30 μL assay containing 20 mM HEPES, pH 7.5, 20...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent